Science Applications International (NASDAQ: SAIC) insider transactions
In the twelve months to 10 November 2026, executives and directors of Science Applications International reported 0 open-market sales and 7 open-market purchases of 4,450 shares ($478,727), by 6 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 22 September 2026 | Cush C. David | Director | Open-market purchase | +1,000 | $132.50 | 1,000 | Form 4 |
| 4 September 2026 | Cush C. David | Director | Grant or award | +1,220 | — | 1,220 | Form 4 |
| 4 September 2026 | DiFronzo Vincent P. | EVP,-Air Force & Space, Intel | Grant or award | +4,210 | — | 6,477 | Form 4 |
| 4 September 2026 | Benson David C | Director | Grant or award | +1,220 | — | 1,220 | Form 4 |
| 2 July 2026 | DiFronzo Vincent P. | EVP,-Air Force & Space, Intel | Gift | −2,682 | — | 2,267 | Form 4 |
| 2 July 2026 | DiFronzo Vincent P. | EVP,-Air Force & Space, Intel | Gift | +2,682 | — | 9,856 | Form 4 |
| 6 June 2026 | McCarthy Kathleen T. | EVP, Chro | Shares withheld for tax | −1,233 | $114.35 | 12,014 | Form 4 |
| 3 June 2026 | Reagan James | CEO | Shares withheld for tax | −742 | $113.36 | 46,950 | Form 4 |
| 3 June 2026 | Eremenko Paul | Director | Grant or award | +2,174 | — | 2,174 | Form 4 |
| 3 June 2026 | Handlon Carolyn B | Director | Grant or award | +1,886 | — | 7,562 | Form 4 |
| 3 June 2026 | McFarland Katharina G. | Director | Grant or award | +1,886 | — | 10,624 | Form 4 |
| 3 June 2026 | McGuirt Milford W | Director | Grant or award | +1,886 | — | 10,371 | Form 4 |
| 3 June 2026 | Morea Donna S | Director | Grant or award | +1,886 | — | 37,040 | Form 4 |
| 3 June 2026 | Rogers Michael Scott | Director | Grant or award | +2,174 | — | 2,174 | Form 4 |
| 3 June 2026 | Shane Steven R | Director | Grant or award | +1,886 | — | 39,971 | Form 4 |
| 3 June 2026 | Tien John K Jr | Director | Grant or award | +1,886 | — | 4,449 | Form 4 |
| 3 June 2026 | Urban David | Director | Grant or award | +1,886 | — | 3,139 | Form 4 |
| 2 June 2026 | Shane Steven R | Director | Option exercise | +2,876 | $77.65 | 40,026 | Form 4 |
| 2 June 2026 | Shane Steven R | Director | Shares withheld for tax | −1,941 | $115.08 | 38,085 | Form 4 |
| 9 April 2026 | Attili Srinivas | EVP, Civilian | Open-market purchase | +100 | $94.96 | 17,656 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Science Applications International page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.